Ireland’s research and innovation landscape entered a new phase in March 2026 with the publication of Research Ireland’s strategy Curiosity, Capability, Competitiveness. The strategy sets quantified enterprise targets: 36 per cent co-funding from multinationals, 16 per cent from SMEs, 50 spin-out companies, and 10 strategic partnerships exceeding €10 million each. Established in August 2024 from Science Foundation Ireland and the Irish Research Council, Research Ireland is the single national research and innovation funding agency. For Irish companies, this is not a policy document to note. It is an invitation to act.

The strategy deserves to be read as a commercial opportunity. Ireland has built a research infrastructure that is world-class in areas of direct enterprise relevance: semiconductor design, quantum computing, biopharma, AI, and climate technology. Three dimensions of the 2026 to 2030 agenda create direct opportunities: enterprise partnerships, the spin-out and IP pipeline, and researcher talent mobility.

On enterprise partnerships, the return is demonstrable. The Research Ireland Enterprise Partnership Scheme co-funds postgraduate researchers in company projects at €11,300 per researcher annually from enterprise against a Research Ireland contribution of up to €22,700. UCD spin-out APC Ltd has invested €100 million in a Dublin medicine accelerator with plans to scale to 600 staff. Companies engaging structured research partnerships report accelerated product development and stronger talent pipelines.

The spin-out and commercialisation targets are equally significant. Research Ireland targets 50 spin-out companies by 2030, building on a track record that includes Equal1, the UCD quantum computing spin-out which has raised €73 million and partnered with NVIDIA. Ireland’s Horizon 2020 drawdown reached €1.21 billion, on track to exceed the €1.5 billion Horizon Europe target. For companies seeking innovation at European scale, Ireland’s research infrastructure and Horizon access is a strong base.

The talent mobility dimension is the most commercially underutilised opportunity. Research Ireland targets 3,800 PhDs and 2,000 postdoctoral fellows alongside structured movement between academia and industry. Horizon Europe carries a €1.4 billion budget for 2025, with a new €300 million EIC STEP Scale-up scheme offering €10 to €30 million per company. Irish companies with innovation functions connected to the researcher pipeline access talent and co-funding unavailable through any other route.

Three practical actions follow. Companies with university relationships should map R&D priorities against Research Ireland’s 14 enhanced Research Centres and the Enterprise Partnership Scheme, identifying co-investment opportunities in the current cycle. Innovation directors should engage Enterprise Ireland’s Innovation Partnership Programme as a route into the Research Ireland ecosystem. Boards should treat Research Ireland’s MNC co-funding target of 36 per cent as a benchmark for their own research investment in Ireland.

Ireland’s research and innovation system is entering its most ambitious phase. The 2026 to 2030 strategy, combined with strong Horizon Europe performance and a maturing spin-out ecosystem, rewards proactive enterprise engagement. Companies that embed research partnerships, contribute to the commercialisation pipeline, and connect talent strategies to the PhD and postdoctoral pipeline will build advantages that are difficult to replicate. The infrastructure is funded, targets are set, and the invitation to enterprise is open.

(The views expressed by the writer are his/her own and do not necessarily reflect the views or positions of BusinessRiver.)